MolecuLight i:X® Receives FDA 510(k) Clearance for the Device’s Ability to Detect Wounds Likely to Contain Pseudomonas aeruginosa (PA)
- Thursday, September 23, 2021, 5:31
- PR Newswire
- Add a comment
New FDA Clearance Illustrates the Utility of the i:X to Reliably Predict Pseudomonas aeruginosa, a Bacterial Pathogen that Precludes Wound Healing and Often Evades Conventional Treatment Methods TORONTO, Sept. 23, 2021 /PRNewswire/ – MolecuLight Inc., the leader in point-of-care…
About the Author
admin has written 20655 stories on this site.